Difference between revisions of "Pediatric Lomustine Dosing Chart"
Jump to navigation
Jump to search
(Created page with "{{#lst:Section editor transclusions|peds}} <big>''This page contains studies that were specific to pediatric populations. For the more general AML page, follow Acute myeloid...") |
|||
| Line 8: | Line 8: | ||
{{TOC limit|limit=3}} | {{TOC limit|limit=3}} | ||
| − | = | + | =ACNS Lomustine Dosing Nomogram= |
{| class="wikitable" style="width: 40%; text-align:center;" | {| class="wikitable" style="width: 40%; text-align:center;" | ||
Revision as of 10:41, 5 November 2021
Section editor transclusions This page contains studies that were specific to pediatric populations. For the more general AML page, follow this link.
0 regimens on this page
0 variants on this page
|
ACNS Lomustine Dosing Nomogram
| Body Surface Area (m2) | Ideal Dose (75 mg/m2/day once daily) | Actual Dose to be Given (200 mg/m2/day once daily) |
|---|---|---|
| 2.0 | 150 mg, | 150 mg |
| 1.9 | 143 | 140 |
| 1.8 | 135 | 130 |
| 1.7 | 128 | 130 |
| 1.6 | 120 | 120 |
| 1.5 | 112 | 110 |
| 1.4 | 105 | 100 |
| 1.3 | 98 | 100 |
| 1.2 | 90 | 90 |
| 1.1 | 82 | 80 |
| 1.0 | 75 | 80 |
| 0.95 | 71 | 70 |
| 0.9 | 68 | 70 |
| 0.85 | 64 | 60 |
| 0.8 | 60 | 60 |
| 0.75 | 56 | 60 |
| 0.7 | 53 | 50 |
| 0.65 | 49 | 50 |
| 0.6 | 45 | 40 |
| 0.55 | 41 | 40 |
| 0.5 | 38 | 40 |
| 0.45 | 34 | 30 |
| 0.4 | 30 | 30 |
| 0.35 | 26 | 30 |
| 0.3 | 23 | 20 |